Match Document Document Title
6605447 Methods and means of detecting nitric oxide synthase  
Methods for identifying and monitoring increased or decreased levels of inducible nitric oxide synthase in biological samples are provided. A collection device for detecting inducible nitric oxide...
6602506 Delivery of proteins into eukaryotic cells with recombinant Yersinia  
The present invention relates to recombinant Yersinia and the use thereof for delivery of proteins into eukaryotic cells, including related compositions and methods of treatment and related assays.
6599502 Intracellular delivery vehicles  
The invention provides methods and compositions relating to intracellular delivering of agents to eukaryotic cells. The compositions include microbial delivery vehicles such as nonvirulent bacteria...
6599503 Biocontrol of plant diseases caused by Fusarium species with novel isolates of Bacillus megaterium  
Microbiological agents are provided for control of certain diseases of wheat and other cereals caused by Fusarium species, including Fusarium head blight of wheat and other cereals. These agents...
6596516 Process for the fermentative preparation of L-amino acids using coryneform bacteria  
A process for the preparation of L-amino acids, in which the following steps are carried out, a) fermenting the desired L-amino acid-producing bacteria in which at least the glyA gene is...
6593133 Neurotrophic factors  
The invention relates to neublastin neurotrophic factor polypeptides, nucleic acids encoding neublastin polypeptides, and antibodies that bind specifically to neublastin polypeptides, as well as...
6589777 Stereoselective microbial reduction of a racemic tetralone  
The present invention relates to processes for carrying out the following stereoselective microbial reduction of a racemic tetralone: which comprises: contacting a compound of formula (I) with a...
6590087 whmD, an essential cell division gene from mycobacteria  
A whmD gene that controls sporulation in mycobacteria, vectors and transformed cells containing the gene.
6586184 Chimeric mutational vectors  
The invention is based on the discovery that recombinagenic oligonucleobases are active in prokaryotic cells that contain a strand transfer activity (RecA) and mismatch repair activity (MutS)....
6586227 Non-virulent Porphyromonas gingivalis mutant  
The Porphyromonas gingivalis strain which is deposited at ATCC under accession number 202109. A pharmaceutical composition comprising the Porphyromonas gingivalis strain of the present invention.
6586393 Antibiotics GE 23077, pharmaceutically acceptable salts and compositions, and use thereof  
The invention relates to an antibiotic substance of microbial origin, arbitrarily denominated GE23077 complex and the individual factors which constitute it, a mixture of said factors in any...
6586578 Defl  
The invention provides Defl polypeptides and DNA (RNA) encoding Defl polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing Defl...
6579712 System for reproducing and dispensing bio-cultures for bio-augmentation and method therefor  
A system for reproducing and dispensing bio-cultures for bio-augmentation, and method therefor. The system comprises a bacteria solution breeding tank, a bacteria solution dispensing metering pump...
6579711 Lactic acid bacteria species  
Strain of lactic acid bacterium, (1) whose 16S ribosomal RNA is characteristic of the genus Streptococcus, (2) whose total protein profile, obtained after migration of the total proteins on an...
6576449 Microbial production of epoxides  
A method for microbial production of epoxides and other oxygenated products is disclosed. The method uses a biocatalyst of methanotrophic bacteria cultured in a biphasic medium containing a major...
6573087 Packaged timed release microorganisms and absorbent matrix for degradation of hydrocarbons  
An absorbent package for containment and bioremediation of hydrocarbons and method thereof are disclosed. The package comprises a concentration of microorganisms, a timed release mechanism...
6566120 Conversion of compactin to pravastatin by Actinomadura  
A method for converting compactin to pravastatin is described. Compactin is provided and contacted with an agent derived from Actinomadura under conditions in which the agent converts compactin to...
6565856 Compounds and methods for treatment and diagnosis of chlamydial infection  
Compounds and methods for the diagnosis and treatment of Chlamydial infection are disclosed. The compounds provided include polypeptides that contain at least one antigenic portion of a Chlamydia...
6565846 Microbial strains of pseudomonas, bacillus and enterobacter/in agricultural chemical compositions  
A method for screening a bacterium antagonistic to pathogenic bacteria that emerge during raising of seedlings of gramineous plants utilizing tropolone resistance and tropolone non-producing...
6558678 PREPARATION AND USE OF FORMALIN-KILLED COLONIZATION-FACTOR-ANTIGEN (CFA)-EXPRESSING E. COLI ORGANISMS FOR VACCINATION AGAINST ENTERIC INFECTION/DIARRHEA CAUSED BY ENTEROTOXIGENIC E. COLI BACTERIA IN HUMANS  
Disclosed is a method of producing a vaccine composition against enteric infection caused by enterotoxigenic E. coli bacteria in humans. E. coli strains selected from different known strains...
6558940 Streptomyces strain with potential anti-microbial activity against phytopathogenic fungi  
The present invention relates to a new strain of Streptomyces sp., called CIMAP A 1 isolated from the soil of geranium ( Pelargonium graveolens ) planted in the experimental fields of CIMAP and...
6551814 Methods for bioremediation by degrading toluene  
Compositions and methods for the degradation of compounds contained in a liquid or solid waste stream are provided. Genes encoding toluene-degrading enzymes are also provided. The enzymes have...
RE38088 Immunoassay for H. Pylori in fecal specimens  
A process for the determination of H. Pylori in a fecal specimen comprising (a) dispersing a fecal specimen suspected of carrying H. pylori in a sample diluent; (b) contacting the fecal specimen in...
6551591 Antibiotics from microbispora  
The present invention provides a novel strain of Microbispora corallina , means for identifying it, methods for culturing it at several different levels, two new antibiotics derived from the...
6548288 Method for producing high density antagonistic microbe base material and high density antagonistic microbes produced by the same  
The present invention discloses high density antagonistic microbe base materials and a method of producing the same, more particularly, a method for preparing high density antagonistic microbe base...
6548057 Bifidobacterium breve ferm BP 6223 for producing fermented soymilk  
A Bifidobacterium breve strain provided is showing a viable count of 1×10 9 cells/ml or more immediately after culturing in a soymilk medium and sustaining a viable count of 1×10 8 cells/ml...
6548289 Biological nitrogen fixation  
Method for increasing the rate of conversion of atmospheric nitrogen into ammonia in a microorganism of the genus Rhizobium, by increasing the intracellular level of an activator protein which is...
6541240 Bacterial cleavage of only organic C-N bonds of carbonaceous materials to reduce nitrogen content  
A microbial process is provided for selective cleavage of only organic C—N bonds while leaving C—C bonds intact which may be used for reducing the nitrogen content of nitrogen-containing...
6541199 Identification of a new ehrlichia species from a patient suffering from ehrlichiosis  
A new isolate of Ehrlichia species has been obtained from a patient suffering from ehrlichiosis. The new isolate has been found to be similar, but distinctly different from E. canis . A diagnostic...
6540997 Shelf-stable, virulent preparation containing Agrobacterium cells, an acidulant and a phenolic compound  
A virulent preparation of Agrobacterium cells, includes Agrobacterium cells, an acidulant, and a phenolic compound that is preferably ethyl vanillin. A method of preparing the preparation includes...
6541027 Lactic acid bacteria with anxiolytic properties and uses thereof  
The invention concerns lactic acid bacteria with anxiolytic properties and not inducing sedative effect. Said lactic acid bacteria are useful in particular for preparing foods or medicines.
6537795 Method and means for the production of hyaluronic acid  
A method for selecting streptococcus strains capable of producing hyaluronic acid with molecular weight exceeding six million includes the steps of cultivating strains of streptococci individually...
6537797 Compositions and methods useful in bioremediation of polychlorinated biphenyls  
The invention includes an isolated bacterium and a consortium of microorganisms including an isolated bacterium of the invention, which is capable of utilizing as a sole carbon source a...
6534286 Protein production in Aureobasidium pullulans  
The present disclosure provides methods and DNA molecules for the synthesis of heterologous proteins in the fungus Aureobasidium pullulans either intracellularly or with secretion out of the...
RE38028 Molecular genetic construction of vaccine strains of pasteurellaceae  
Tools for genetically engineering Pasteurellaceae are provided. Replication-conditional plasmids which are useful for the Pasteurellaceae have been isolated and characterized. The plasmids can be...
6528498 Selection and/or enhancement of resident microorganisms in the gastrointestinal tract  
Improved method of enhancing a population of one or more target micoorganisms in the gastrointestinal tract of an animal, the improvement comprising providing to the animal a selected modified or...
6528303 Neuropeptide Y-Y5 receptor  
The invention provides isolated DNA molecules encoding the human, mouse and rat NPY-Y5 receptors. These isolated DNA molecules can be used to express the NPY-Y5 receptors in cells which can then be...
6528251 Method of managing the chemotherapy of patients who are HIV positive based on the phenotypic drug sensitivity of human HIV strains  
The present invention is drawn to A method of managing HIV chemotherapy of patients who are HIV positive, which comprises transfecting a cell line susceptible to infection by HIV with a sequence...
6528301 Paclitaxel production by actinomycetes  
The present invention related to microorganisms producing taxanes, such as paclitaxel or related taxanes, to the use of said microorganisms for the production of taxanes, and to the procedure for...
6524590 Identification of a new ehrlichia species from a patient suffering from ehrlichiosis  
A new isolate of Ehrlichia species has been obtained from a patient suffering from ehrlichiosis. The new isolate has been found to be similar, but distinctly different from E. canis . A diagnostic...
6524792 Expression cloning processes for the discovery, characterization and isolation of genes encoding polypeptides with a predetermined property  
The present invention is directed to a method for detection, characterization and isolation of nucleic acids encoding proteins of a desired property, such as a particular cellular localization. The...
6517845 Mycobacterium tuberculosis superoxide dismutase  
The invention relates to Mycobacterium tuberculosis superoxide dismutase antibodies, methods of using them for detection of M. tuberculosis , methods of testing for an inhibitor of an M....
6514744 External compositions for skin comprising sphingoglycolipid  
A sphingoglycolipid represented by the following formula: obtained from a bacterium of the genus Sphingomonas, further from the species paucimobilis, capsulate or adhaesiva, after being washed...
6506380 Methods of preventing or treating allergies  
The present invention provides method of making a protein hydrolysate formula and protein hydrolysate formulas made thereby for downregulating hypersensitivity and for promoting gut immune barrier,...
6506590 Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins  
The present invention relates to the construction and use of expression plasmids in the manufacture of recombinant interleukin-4 (IL-4) and interleukin-4 muteins.
6506389 ADHERENCE FACTORS OF NON PATHOGENIC MICROORGANISMS AND APPLICATIONS THEREOF FOR SCREENING MICROORGANISMS FOR SPECIFIC PROBIOTIC PROPERTIES; NOVEL PHARMACEUTICAL COMPOSITIONS AND FOOD ADDITIVES COMPRISING SUCH MICROORGANISMS AND ADHERENCE FACTORS  
A protein obtainable from a non pathgenic microorgansim, said protein having mucosa binding promoting activity and a molecular weight of 20-40 kD is disclosed. Application of such a protein or a...
6503746 Biologically pure Paenibacillus validus bacterial strains that degrade polyaromatic hydrocarbons  
Polyaromatic hydrocarbons are found in contaminated soils and groundwater and are a large class of compounds for which treatment by bioremediation is sought. Accordingly, indigenous organisms that...
6492176 Increase of nodule number and nitrogen fixation in leguminosae  
The present invention relates to a new mutant Rhizobium etli CNPAF 512 strain, having an inactivated raiI gene. Inactivation of the raiI gene leads to increased nodule number in beans upon...
6491910 Ovo administration of a competitive exclusion culture  
An improved method of competitively excluding pathogens capable of intestinal colonization, such as Salmonella or Cambylobacter, from a digestive tract of a bird comprises administration in ovo to...
6485938 Nucleic acid molecules that encodes human Zven1  
The present invention provides two members of a new family of human proteins, designated as “Zven.” The Zven1 gene, which resides in human chromosome 3p21.1-3p14.3, is expressed in testicular...